Burzynski Research Institute Inc Sample Contracts

Burzynski Research Institute Inc – Marketing and Consulting Agreement (July 6th, 2012)

This Marketing and Consulting Agreement (“Agreement”) is entered into this 5th day of July, 2012, by and among Burzynski Research Institute, Inc., a Delaware corporation (including its successors or permitted assigns, “BRI”), a Delaware corporation,  Worldwide Medical Consultants, Inc., a Delaware corporation (“Consultant”), and CARIGEN, LTD, a Cayman Island company (including its successors or permitted assigns, “SRB”).

Burzynski Research Institute Inc – FITTSROBERTS® & Co., P.C. CERTIFIED PUBLIC ACCOUNTANTS AND CONSULTANTS May 21, 2009 Securities and Exchange Commission Washington, D.C. 20549 Commissioners: We are the predecessor independent registered public accounting firm for Burzynski Research Institute, Inc. (the Company). We have read the Company’s disclosure set forth in item 4.01 Changes in Registrants Certifying Accountants of the Company’s Current Report on Form 8-K dated May 18, 2009 (the Current Report) and are in agreement with the disclosures in the Current Report, insofar as it pertains to our firm, Fitts, Roberts & Co., P.C. F (May 22nd, 2009)
Burzynski Research Institute Inc – THIRD AMENDMENT TO THE RESEARCH FUNDING AGREEMENT (May 29th, 2007)

On or about February 29, 2004, Dr. Stanislaw R. Burzynski and the Burzynski Research Institute, Inc. (BRI) entered into a Second Amendment to the Research Funding Agreement, under which funding agreement, inter alia, Dr. Burzynski agreed to fund the research undertaken by BRI.

Burzynski Research Institute Inc – SECOND AMENDMENT TO THE RESEARCH FUNDING AGREEMENT (June 1st, 2004)

This Second Amendment to the Research Funding Agreement is dated as of February 29, 2004.  On or about March 1, 2001, Dr. Stanislaw R. Burzynski and the Burzynski Research Institute, Inc. (BRI) entered into a First Amendment to the Research Funding Agreement, under which funding agreement, inter alia, Dr. Burzynski agreed to fund the research undertaken by BRI.

Burzynski Research Institute Inc – RESEARCH FUNDING AGREEMENT (October 15th, 2003)

THIS AGREEMENT effective as of March 1,1997, by and between Stanislaw R. Burzynski, M.D. Ph.D (hereinafter “SRB”) having his principal place of business at 12000 Richmond Avenue, Houston, Texas and the Burzynski Research Institute, Inc., a Delaware Corporation (“BRI”) having its principal place of business at 12000 Richmond Avenue, Houston Texas hereby agree as follows:

Burzynski Research Institute Inc – FIRST AMENDMENT TO RESEARCH FUNDING AGREEMENT This First Amendment To Research Funding Agreement (the "Amendment"), effective as of March 1, 2001, is entered into by and between Stanislaw R. Burzynski, M.D., PhD. ("Dr. Burzynski") and Burzynski Research Institute, Inc., a Delaware corporation (the "Company"). WHEREAS, the Company and Dr. Burzynski entered into that certain Research Funding Agreement (the "Agreement"), effective as of March 1, 1997, pursuant to which the Company agreed to undertake all scientific research in connection with the development of new or improved antineoplastons for (May 2nd, 2001)
Burzynski Research Institute Inc – RESEARCH FUNDING AGREEMENT (November 25th, 1997)
Burzynski Research Institute Inc – AMENDED LICENSE AGREEMENT (November 25th, 1997)
Burzynski Research Institute Inc – ROYALTY AGREEMENT (November 25th, 1997)
Burzynski Research Institute Inc – FIRST AMENDED ROYALTY AGREEMENT (November 25th, 1997)